These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 10731533

  • 1. Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
    Wu X, Sallinen K, Zhou S, Su Y, Pöllänen P, Erkkola R.
    Fertil Steril; 2000 Apr; 73(4):730-4. PubMed ID: 10731533
    [Abstract] [Full Text] [Related]

  • 2. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP, Hatziioanidis AH, Trovas GP, Misichronis GS, Kounadi TG, Devetzaki OA, Andronis CK, Rangou DB, Chlouverakis CS.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [Abstract] [Full Text] [Related]

  • 3. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F, Palomba S, Colao A, Russo T, Dentico C, Tauchmanovà L, Savastano S, Nappi C, Sultan C, Zullo F, Lombardi G.
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [Abstract] [Full Text] [Related]

  • 4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 5. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
    Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M.
    Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
    Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
    [Abstract] [Full Text] [Related]

  • 7. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.
    Wu XK, Zhou SY, Sallinen K, Pöllänen P, Erkkola R.
    Eur J Endocrinol; 2000 Sep; 143(3):383-8. PubMed ID: 11022181
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome.
    Amin AF, Abd el-Aal DE, Darwish AM, Meki AR.
    Fertil Steril; 2003 Apr; 79(4):938-41. PubMed ID: 12749434
    [Abstract] [Full Text] [Related]

  • 9. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 10. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
    Cortet-Rudelli C, Pigny P, Decanter C, Leroy M, Maunoury-Lefebvre C, Thomas-Desrousseaux P, Dewailly D.
    Fertil Steril; 2002 Feb; 77(2):281-7. PubMed ID: 11821084
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.
    Lee EJ, Lee BS, Lee HC, Park KH, Song CH, Huh KB.
    Fertil Steril; 1993 Jul; 60(1):53-7. PubMed ID: 8513959
    [Abstract] [Full Text] [Related]

  • 12. Lack of insulin-like growth factor binding protein-3 variation after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization.
    Amato G, Izzo A, Tucker AT, Bellastella A.
    Fertil Steril; 1999 Sep; 72(3):454-7. PubMed ID: 10519616
    [Abstract] [Full Text] [Related]

  • 13. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 14. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
    Dale PO, Tanbo T, Vaaler S, Abyholm T.
    Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640
    [Abstract] [Full Text] [Related]

  • 15. Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome.
    Liguori G, Tolino A, Moccia G, Scognamiglio G, Nappi C.
    Gynecol Endocrinol; 1996 Aug; 10(4):257-64. PubMed ID: 8908526
    [Abstract] [Full Text] [Related]

  • 16. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
    Carmina E, Wong L, Chang L, Paulson RJ, Sauer MV, Stanczyk FZ, Lobo RA.
    Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
    [Abstract] [Full Text] [Related]

  • 17. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
    Cheung AP, Pride SM, Yuen BH, Sy L.
    Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525
    [Abstract] [Full Text] [Related]

  • 18. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 19. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 May; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 20. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C, Renteria JL, Moran S, Herrera J, Gonzalez S, Bermudez JA.
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.